# Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds

> **NCT00704262** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 33 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Calcipotriol plus hydrocortisone (LEO 80190)

## Key facts

- **NCT ID:** NCT00704262
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704262, "Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00704262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*